Genomic News and Research

RSS

CRG launches Europe's first continent-wide PhD training program for medical doctors

The Centre for Genomic Regulation in Barcelona has today launched Europe's first continent-wide PhD training programme for medical doctors.

13 Sep 2021

MD Anderson and SNIPR BIOME join forces to advance new CRISPR-based microbiome therapeutics

The University of Texas MD Anderson Cancer Center and SNIPR BIOME today announced a strategic collaboration to advance new CRISPR-based microbiome therapeutics to reduce immune-related adverse events (irAE) in patients being treated with combined immune checkpoint inhibitors.

13 Sep 2021

Lessons from COVID-19 response during first three waves in New South Wales

Scientists from Australia have recently analyzed the public health measures adopted by the authorities during the three waves of coronavirus disease 2019 (COVID-19) pandemic in New South Wales, Australia.

12 Sep 2021

Genomic surveillance of SARS-CoV-2 reveals how the pandemic was caused in Africa

A genomic surveillance analysis of SARS-CoV-2 in Africa in the first year of the pandemic reveals that the first phase of the pandemic there was caused by importations from outside Africa, and involved limited virus spread, while the second, more deadly phase was fueled by ongoing transmission within the continent and led to emergence of many variants of concern.

10 Sep 2021

SARS-CoV-2 transmission dynamics in Nordic countries

Scientists have recently assessed the strategies adopted by the Nordic countries to curb the trajectory of the COVID-19 pandemic.

10 Sep 2021

Washington University School of Medicine receives $7 million to investigate how human genome works

Washington University School of Medicine in St. Louis has received a $7 million grant from the National Institutes of Health to help lead national efforts to investigate how variations in the human genome sequence affect how the genome functions.

9 Sep 2021

UC San Diego researchers receive $6 million NIH grant to study insulin-producing cells

Sequencing the human genome - a feat accomplished in 2003 - provided the list of ingredients that make up a human being, but not the instructions that explain how those ingredients are used by each cell type to create complex "meals."

9 Sep 2021

IGVF consortium receives NIH funding to study how genomic variation influences biological function

The National Institutes of Health is providing approximately $185 million over five years to the Impact of Genomic Variation on Function consortium, initiated and funded by NIH's National Human Genome Research Institute.

9 Sep 2021

Highly extensive Gut Cell Atlas will transform research into intestinal diseases

Many diseases have their origin in early human development, and today (8th September), two publications in Nature reveal how researchers from the Human Cell Atlas (HCA) consortium are advancing understanding of this.

9 Sep 2021

Are bat retroviruses a threat to humans?

Zoonotic viruses that bats transmit are capable of infecting humans and have caused devastating infections throughout the world.

9 Sep 2021

Healthy plant-based foods may lower COVID-19 risk and severity

Although metabolic conditions such as obesity and type 2 diabetes have been linked to an increased risk of COVID-19, as well as an increased risk of experiencing serious symptoms once infected, the impact of diet on these risks is unknown.

9 Sep 2021

New open-access repository of FAQs on human genomic research counters misinformation

New research on the genomic influences on traits such as intelligence, household income, and sexual behavior captures public attention, but it is also used to justify beliefs in racial and social inequalities.

7 Sep 2021

Polygenic risk score no better at predicting psychosis outcomes than written reports, study finds

With the help of cutting-edge computer programs, researchers at the Icahn School of Medicine at Mount Sinai went through the genetic and medical records of more than 8,000 schizophrenia patients.

6 Sep 2021

New insights could help unlock the mystery of how lung cancer arises in never smokers

A genomic analysis of lung cancer in people with no history of smoking has found that a majority of these tumors arise from the accumulation of mutations caused by natural processes in the body.

6 Sep 2021

Cancer treatment with terpyridine platinum compounds induces telomere dysfunction, chromosome instability

Oncotarget published "Terpyridine platinum compounds induce telomere dysfunction and chromosome instability in cancer cells" which reported that this assay is based on the use of two isogenic HT1080 cell lines, one carrying a linear HAC and the other carrying a circular HAC.

6 Sep 2021

Delta variant has a more diverse repertoire of mutations than other variants

In a paper, nearly 2 million SARS-CoV-2 genomes from around the world were analyzed, finding great diversity within the delta variant that exceeds that observed in the more widely spread alpha variant.

6 Sep 2021

mRNA COVID-19 vaccine protection wanes after six months: a wide-scale study of the population of Qatar

In a paper recently uploaded to the preprint server medRxiv* by Chemaitelly et al. (August 27, 2021), the long-term effectiveness of the mRNA vaccines is analyzed amongst the Qatar population. The study observed waning protection against infection around six months post-vaccination but lasting protection from death and hospitalization.

6 Sep 2021

Increased evolutionary rates seen in SARS-CoV-2 variants of concern

An Australian study conducted at the University of Melbourne describes that the emergence of more deadly variants of concern (VOCs) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with an induction in episodic evolutionary rate. The study is currently available on the medRxiv* preprint server.

2 Sep 2021

A global genetic surveillance gap for SARS-CoV-2

Now a new study posted to the medRxiv* preprint server provides a perspective on the global disparities surrounding SARS-CoV-2 genomic surveillance, their causes and consequences, and possible solutions to maximize the impact of pathogen genome sequencing for efforts on public health.

1 Sep 2021

Development of SARS-CoV-2 antibody escape variants in an immunocompromised individual

A new study published in mBio discusses the microevolution of SARS-CoV-2.

31 Aug 2021

Genomic News and Research

CRG launches Europe's first continent-wide PhD training program for medical doctors

MD Anderson and SNIPR BIOME join forces to advance new CRISPR-based microbiome therapeutics

Lessons from COVID-19 response during first three waves in New South Wales

Genomic surveillance of SARS-CoV-2 reveals how the pandemic was caused in Africa

SARS-CoV-2 transmission dynamics in Nordic countries

Washington University School of Medicine receives $7 million to investigate how human genome works

UC San Diego researchers receive $6 million NIH grant to study insulin-producing cells

IGVF consortium receives NIH funding to study how genomic variation influences biological function

Highly extensive Gut Cell Atlas will transform research into intestinal diseases

Are bat retroviruses a threat to humans?

Healthy plant-based foods may lower COVID-19 risk and severity

New open-access repository of FAQs on human genomic research counters misinformation

Polygenic risk score no better at predicting psychosis outcomes than written reports, study finds

New insights could help unlock the mystery of how lung cancer arises in never smokers

Cancer treatment with terpyridine platinum compounds induces telomere dysfunction, chromosome instability

Delta variant has a more diverse repertoire of mutations than other variants

mRNA COVID-19 vaccine protection wanes after six months: a wide-scale study of the population of Qatar

Increased evolutionary rates seen in SARS-CoV-2 variants of concern

A global genetic surveillance gap for SARS-CoV-2

Development of SARS-CoV-2 antibody escape variants in an immunocompromised individual

The art of CRISPR: The power and promise of gene editing eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News